SULIQUA 100/33 sol inj SoloStar ve stylo pré 3 pce
7680662830035
CH-66283
A10AE
07.06.
Reimbursement limitations:
SULIQUA
Suliqua est utilisé en association avec de la metformine dans le traitement du diabète de …
1 / 3
google
Details
- Product number
- 6628302
- CPT
- -
- Packaging group
- 3
- Unit
- Stück
- Composition
- insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 U., lixisenatidum 33 µg, zinci chloridum, glycerolum (85 per centum), methioninum, conserv.: metacresolum 2.7 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Suliqua 100/33, solution injectable
Injektionslösung
3
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
3.64 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
100.0 U | Substance | WIIS |
|
(N/A)
|
33.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.7 MG | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 93.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2018
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 66283
- Drug name
- Suliqua, solution injectable
- Galenic form
- LSPA
- ATC Code
- A10AE
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 05/10/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 07.06.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SULIQUA 100/33 sol inj SoloStar ve stylo pré 3 pce
- Description (DE)
- SULIQUA 100/33 Inj Lös SoloStar grün Fertpen 3 Stk
- Market launch
- 05/10/2017
- Narcotic (BTM)
- No